New skin injection aims to tame severe eczema in global trial
Disease control
Not yet recruiting
This study is testing an injectable medication called MG-K10 for people aged 12 and older with moderate-to-severe atopic dermatitis (eczema) that hasn't improved enough with standard creams. The goal is to see if MG-K10 is safe and effective at reducing the itchy, inflamed skin r…
Phase: PHASE3 • Sponsor: Shanghai Mabgeek Biotech.Co.Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC